A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2011
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287262 Nanoparticles, nanocapsules and nanogels
11/24/2011	US20110287115 Standardization of Botanical Products Utilizing Biological Activity as a Marker
11/24/2011	US20110287102 Chain extenders
11/24/2011	US20110287073 Emulsion Concentrate
11/24/2011	US20110287068 Fibrin and fibrinogen matrices and uses of same
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
11/24/2011	US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels
11/24/2011	US20110287015 Mg53 compositions and methods of use
11/24/2011	US20110287012 Nucleic acid encoding cytokine receptor zcytor17
11/24/2011	US20110287004 Mg53 compositions and methods of use
11/24/2011	US20110286989 ANGIOGENIN COMPLEXES (ANGex) WITH LIPID-BASED SUBSTRATES AND USES THEREOF
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	CA2799942A1 Pharmaceutical composition containing solifenacin
11/24/2011	CA2798735A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
11/24/2011	CA2790170A1 Treatment for altitudinal hypoxia
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388245A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
11/23/2011	EP2387998A1 Methods for treating degenerative diseases/injuries
11/23/2011	EP2387567A2 Methods for screening and compounds that protect against amyloid diseases
11/23/2011	EP2387420A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
11/23/2011	EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1087779B1 Compositions for increasing energy in vivo
11/23/2011	EP0948358B2 Stable liquid interferon formulations
11/23/2011	CN1897973B Application of lactoferrin and polyinosinicacid in proliferation agent combinations of preparation of animal nature killer cells
11/23/2011	CN102256623A Neuroinvasion inhibitor
11/23/2011	CN102250181A Polyhydroxy steroid compounds and purpose thereof
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN101961460B Chinese medicinal health-care composition and preparation method thereof
11/23/2011	CN101816767B External Chinese medicament for treating goitre
11/23/2011	CN101723890B Aryl thiourea and preparation method and application thereof
11/23/2011	CN101703733B Medicament for treating tumor-like diseases
11/23/2011	CN101336230B Pharmaceutical for use in the treatment of ureterolithiasis
11/23/2011	CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
11/22/2011	US8063242 2-aryl-propionic acids and pharmaceutical compositions containing them
11/22/2011	US8063081 Aryl carbonyl derivatives as therapeutic agents
11/22/2011	US8063078 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
11/22/2011	US8063070 Bicyclic benzamides of 3-or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/22/2011	US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
11/22/2011	US8063013 Method of treating glaucoma comprising administering a composition comprising human BMP7
11/22/2011	CA2653830C 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
11/22/2011	CA2493940C Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011	CA2486917C Topically applicable pharmaceutical preparation containing roflumilast
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/22/2011	CA2482826C Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
11/22/2011	CA2473874C A composition for treating neurocerebrovascular disorders
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2444278C Modified cyclosporine which can be used as a pro-drug and use thereof
11/22/2011	CA2420893C Method of obtaining a hydroxytyrosol-rich composition from vegetation water
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2352324C Derivatives of (-)-venlafaxine and methods of preparing and using the same
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/17/2011	WO2011142359A1 Spiro compound and drug for activating adiponectin receptor
11/17/2011	WO2011142300A1 Reducing agent from microorganism belonging to genus bacillus and application for same
11/17/2011	WO2011142246A1 Method for inhibition of potential-dependent cation channel
11/17/2011	WO2011140681A1 Acrylamide compounds and use thereof for inhibiting apoptosis
11/17/2011	WO2011140680A1 Urea compounds and use thereof for inhibiting apoptosis
11/17/2011	WO2011076807A3 Lipids, lipid compositions, and methods of using them
11/17/2011	WO2011057243A3 Administration of plant expressed oral tolerance agents
11/17/2011	WO2011026641A9 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
11/17/2011	US20110281931 Rna sequence-specific mediators of rna interference
11/17/2011	US20110281906 Sustained release formulation for tacrolimus
11/17/2011	US20110281894 Hemifumarate salt
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281847 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281801 Prediction and prevention of preeclampsia
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281794 composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart-beating potential organ donor
11/17/2011	US20110281786 Stem cell expansion enhancing factor and method of use
11/17/2011	US20110280977 Composition for relieving and preventing hangover and beverage comprising composition
11/17/2011	US20110280947 Embolization
11/17/2011	US20110280885 Cancer immunotherapy
11/17/2011	US20110280864 Low Viscosity Highly Concentrated Suspensions
11/17/2011	US20110280862 Gep and drug transporter regulation, cancer therapy and prognosis
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280825 Extracorporeal devices and methods of treating complications of pregnancy
11/17/2011	US20110280803 Radioiodination method
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/17/2011	US20110277339 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
11/16/2011	EP2386861A2 Cross-ß structure binding compounds
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386551A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011	EP2386550A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386543A1 3-Z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386310A2 Methods for preserving organs and tissues
11/16/2011	EP2385841A1 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
11/16/2011	EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity

1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 1564